| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.14B | $2.04B | $1.78B | $1.73B | $1.36B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.43B | $1.41B | $1.22B | $1.18B | $971.14M |
| R&D | – | – | – | – | – |
| SG&A | $133.01M | $138.14M | $136.81M | $119.53M | $104.12M |
| Operating Income | $770.82M | $629.09M | $638.78M | $565.46M | $424.29M |
| Interest Expense | $330.20M | $307.81M | $250.20M | $226.82M | $204.13M |
| Tax Expense | $1.05M | $25.42M | $60.95M | $56.65M | $3.38M |
| Net Income | $584.74M | $410.79M | $654.27M | $125.98M | $844.06M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $675.28M | $672.14M | $618.20M | $617.86M | $511.38M |